Similar Articles
731 African Americans are less likely to receive curative treatment for hepatocellular carcinoma
732 Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
733 Incident hepatocellular carcinoma developing during tenofovir alafenamide treatment as a rescue therapy for multi-drug resistant hepatitis B virus infection: A case report and review of the literature
734 Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus
735 Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
736 Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation
737 New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
738 Cerebral lipiodol embolism related to a vascular lake during chemoembolization in hepatocellular carcinoma: A case report and review of the literature
739 Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
740 Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA